Glucagon evidence, regulatory status, intended use, known risks, and limitations.
Regulatory status
FDA-approved in multiple product-specific forms
Quick verdict
An evidence-backed prescription option for its specific FDA-approved indication. Individual decisions require a licensed clinician.
At a glance
Primary use: Emergency treatment of severe hypoglycemia; other uses depend on product. Evidence strength: Strong — FDA-reviewed product-specific evidence. Prescription treatment and clinician supervision are required.
What it is
Glucagon is a peptide hormone used in approved products, including emergency treatments for severe hypoglycemia.
What it’s used for
Emergency treatment of severe hypoglycemia; other uses depend on product
How it works
Mechanism and pharmacology are described in the current FDA prescribing information; this review does not provide dosing instructions.
Clinical evidence
Strong — FDA-reviewed product-specific evidence. Public claims on this page are limited to the cited regulatory and clinical evidence.
FDA / Regulatory status
FDA-approved in multiple product-specific forms
Administration
Nasal powder or subcutaneous/intramuscular injection, depending on product. Prescription required. Multiple FDA-approved presentations include nasal and ready-to-use or reconstituted injection products. Coverage, copays, availability, and replacement timing vary. FDA records confirm an approved generic glucagon emergency kit; actual pharmacy stock should be checked. No single consumer out-of-pocket cost is assumed.
Potential benefits
FDA-reviewed evidence supports product-specific benefits for labeled indications.
Known risks & side effects
Warnings and contraindications vary by product and can include hypersensitivity, pheochromocytoma, and insulinoma considerations.
Contraindications / Important warnings
Warnings and contraindications vary by product and can include hypersensitivity, pheochromocytoma, and insulinoma considerations.
Who it may be appropriate for
Potentially appropriate only for patients who meet product-specific labeled criteria after clinician assessment.
Evidence gaps
Users and caregivers should follow the specific approved product labeling.
Alternatives
Review established options for the relevant goal and discuss clinically appropriate alternatives with a licensed professional.
Score breakdown
Editorial score 9.1/10 — Clinical Evidence 9.5; Regulatory Status 10; Effectiveness Evidence 9; Safety / Known Risks 8; Access & Convenience 9; Cost Transparency 7.5. Weighted using the published methodology.
Final verdict
A legitimate prescription therapy for specific approved uses, with important product-specific risks and limitations.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.